PL1981506T6 - Długoterminowe leczenie zakażenia HIV z zastosowaniem TCM278 - Google Patents

Długoterminowe leczenie zakażenia HIV z zastosowaniem TCM278

Info

Publication number
PL1981506T6
PL1981506T6 PL07712053T PL07712053T PL1981506T6 PL 1981506 T6 PL1981506 T6 PL 1981506T6 PL 07712053 T PL07712053 T PL 07712053T PL 07712053 T PL07712053 T PL 07712053T PL 1981506 T6 PL1981506 T6 PL 1981506T6
Authority
PL
Poland
Prior art keywords
tcm278
hiv
infection
long term
term treatment
Prior art date
Application number
PL07712053T
Other languages
English (en)
Other versions
PL1981506T3 (pl
Inventor
Lieven Elvire Colette Baert
Guenter Kraus
Gerben Albert Eleutherius Van 't Klooster
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36446113&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1981506(T6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Publication of PL1981506T3 publication Critical patent/PL1981506T3/pl
Publication of PL1981506T6 publication Critical patent/PL1981506T6/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07712053T 2006-01-20 2007-01-19 Długoterminowe leczenie zakażenia HIV z zastosowaniem TCM278 PL1981506T6 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06100677 2006-01-20
EP07712053.3A EP1981506B3 (en) 2006-01-20 2007-01-19 Long term treatment of hiv- infection with tcm278
PCT/EP2007/050516 WO2007082922A2 (en) 2006-01-20 2007-01-19 Long term treatment of hiv- infection with tcm278

Publications (2)

Publication Number Publication Date
PL1981506T3 PL1981506T3 (pl) 2013-08-30
PL1981506T6 true PL1981506T6 (pl) 2021-07-12

Family

ID=36446113

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07712053T PL1981506T6 (pl) 2006-01-20 2007-01-19 Długoterminowe leczenie zakażenia HIV z zastosowaniem TCM278

Country Status (27)

Country Link
US (4) USRE50189E1 (pl)
EP (1) EP1981506B3 (pl)
JP (2) JP5754005B2 (pl)
KR (2) KR101562943B1 (pl)
CN (2) CN101370504A (pl)
AP (1) AP2936A (pl)
AR (1) AR059097A1 (pl)
AU (1) AU2007206901B2 (pl)
BR (1) BRPI0707179A2 (pl)
CA (1) CA2636436C (pl)
CY (1) CY1114089T1 (pl)
DK (1) DK1981506T6 (pl)
EA (1) EA014914B1 (pl)
ES (1) ES2414982T7 (pl)
HR (1) HRP20130544T4 (pl)
IL (1) IL192132A (pl)
ME (1) ME01617B (pl)
MY (1) MY150717A (pl)
NZ (1) NZ569347A (pl)
PL (1) PL1981506T6 (pl)
PT (1) PT1981506E (pl)
RS (1) RS52821B2 (pl)
SG (1) SG170073A1 (pl)
SI (1) SI1981506T1 (pl)
TW (1) TWI458483B (pl)
UA (1) UA96436C2 (pl)
WO (1) WO2007082922A2 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
TWI457136B (zh) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
AR059097A1 (es) 2006-01-20 2008-03-12 Tibotec Pharm Ltd Tratamiento a largo plazo de la infeccion por vih
BRPI0713334B1 (pt) 2006-06-23 2024-02-20 Janssen Sciences Ireland Uc Uso de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]-amino]-2-pirimidinil]-amino]-benzonitrila para tratar ou prevenir infecção por HIV
AU2014200819B2 (en) * 2006-06-23 2016-05-26 Janssen Sciences Ireland Uc Aqueous suspensions of TMC278
AU2016219555B2 (en) * 2006-06-23 2017-08-10 Janssen Sciences Ireland Uc Aqueous suspensions of TMC278
TWI494133B (zh) 2007-03-14 2015-08-01 Tibotec Pharm Ltd 重組用粉末
KR101726615B1 (ko) 2008-12-24 2017-04-13 얀센 사이언시즈 아일랜드 유씨 Ｈｉｖ 치료용 체내 임플란트 장치
JP5897465B2 (ja) * 2009-09-22 2016-03-30 ヤンセン・アールアンドデイ・アイルランド Ｈｉｖ感染の処置及び予防
CA2784530C (en) 2009-12-21 2018-05-22 Janssen R&D Ireland Degradable removable implant for the sustained release of an active compound
KR20170078868A (ko) * 2010-01-27 2017-07-07 비이브 헬쓰케어 컴퍼니 항바이러스 치료
TWI577377B (zh) 2010-09-16 2017-04-11 Ｖｉｉｖ醫療保健公司 醫藥組合物
US9266824B2 (en) 2014-01-13 2016-02-23 Warsaw Orthopedic, Inc. Methods and compositions for making an amino acid triisocyanate
US10406098B2 (en) * 2015-11-16 2019-09-10 Evonik Roehm Gmbh Injection solution comprising a non-nucleoside reverse-transcriptase inhibitor and poly(lactide-co-glycolide)
US20190163877A1 (en) * 2017-11-27 2019-05-30 International Business Machines Corporation Decision support for effective long-term drug therapy
WO2022079739A1 (en) 2020-10-14 2022-04-21 Cipla Limited Fixed dose compositions of cabotegravir and rilpivirine

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
JPH06316524A (ja) 1992-09-11 1994-11-15 Naoyuki Inoue 抗エイズウイルス剤
US6045829A (en) 1997-02-13 2000-04-04 Elan Pharma International Limited Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
UA72189C2 (uk) 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
US6258932B1 (en) 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
CN1174741C (zh) 1999-09-21 2004-11-10 Rtp药品公司 生物活性物质的表面改性微粒组合物
BR0109602A (pt) 2000-03-30 2004-06-29 Bristol Myers Squibb Co Glóbulos de liberação controlada contendo estavudina
US20040115268A1 (en) 2000-04-26 2004-06-17 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
US7638522B2 (en) 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
AU2002364701B8 (en) 2001-11-20 2006-06-22 Alkermes, Inc. Compositions for sustained action product delivery
US6568805B1 (en) * 2001-11-26 2003-05-27 Dan L. Dietz Trust Magnetic buckle for eyeglasses
CA2474056A1 (en) * 2002-01-24 2003-07-31 Sangstat Medical Corporation Combination therapy for treatment of hiv infection
CA2505130C (en) 2002-11-08 2009-10-06 Glaxo Group Limited Pharmaceutical compositions
CA2506244C (en) 2002-11-18 2012-10-30 Phoenix Pharmacologics, Inc. Methods for inhibiting viral replication in vivo
CN102151270A (zh) 2003-02-07 2011-08-17 詹森药业有限公司 预防hiv感染的嘧啶衍生物
HK1079984A1 (zh) 2003-02-21 2006-04-21 Tripep Ab 抑制hiv复制的甘氨酰胺衍生物
CA2577288C (en) * 2004-09-02 2010-11-30 Janssen Pharmaceutica N.V. Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
JP4912309B2 (ja) * 2004-09-02 2012-04-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ４−［［４−［［４−（２−シアノエテニル）−２，６−ジメチルフェニル］アミノ］−２−ピリミジニル］アミノ］ベンゾニトリルの塩酸塩
CN101106972A (zh) 2004-11-16 2008-01-16 伊兰制药国际有限公司 注射用纳米微粒奥氮平制剂
TWI457136B (zh) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
AR059097A1 (es) 2006-01-20 2008-03-12 Tibotec Pharm Ltd Tratamiento a largo plazo de la infeccion por vih
BRPI0713334B1 (pt) 2006-06-23 2024-02-20 Janssen Sciences Ireland Uc Uso de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]-amino]-2-pirimidinil]-amino]-benzonitrila para tratar ou prevenir infecção por HIV
RU2498979C2 (ru) 2007-07-12 2013-11-20 Тиботек Фармасьютикалз Кристаллическая форма 4-[[4-[[4-(2-цианоэтенил)-2,6-диметилфенил]амино]-2-пиримидинил]амино]бензонитрила

Also Published As

Publication number Publication date
JP2013100338A (ja) 2013-05-23
IL192132A (en) 2014-05-28
ES2414982T3 (es) 2013-07-23
WO2007082922A3 (en) 2007-09-20
EP1981506B3 (en) 2021-06-09
EP1981506B1 (en) 2013-03-27
JP5754005B2 (ja) 2015-07-22
US20210177843A1 (en) 2021-06-17
TWI458483B (zh) 2014-11-01
AP2936A (en) 2014-07-31
HK1125828A1 (en) 2009-08-21
PL1981506T3 (pl) 2013-08-30
EP1981506A2 (en) 2008-10-22
UA96436C2 (ru) 2011-11-10
MY150717A (en) 2014-02-28
DK1981506T6 (da) 2021-06-14
AU2007206901B2 (en) 2013-01-31
PT1981506E (pt) 2013-06-25
TW200806295A (en) 2008-02-01
AP2008004535A0 (en) 2008-08-31
DK1981506T3 (da) 2013-06-24
CA2636436C (en) 2014-04-01
CY1114089T1 (el) 2016-07-27
US20240226099A1 (en) 2024-07-11
EA200870183A1 (ru) 2009-12-30
US20110275654A1 (en) 2011-11-10
NZ569347A (en) 2011-07-29
HRP20130544T1 (en) 2013-07-31
WO2007082922A8 (en) 2008-01-03
KR101562943B1 (ko) 2015-10-23
JP2009526758A (ja) 2009-07-23
AU2007206901A1 (en) 2007-07-26
KR20080085194A (ko) 2008-09-23
CA2636436A1 (en) 2007-07-26
HRP20130544T4 (hr) 2021-08-20
ME01617B (me) 2014-09-20
IL192132A0 (en) 2009-08-03
SG170073A1 (en) 2011-04-29
ES2414982T7 (es) 2021-11-05
SI1981506T1 (sl) 2013-08-30
KR101501475B1 (ko) 2015-03-19
US10953009B2 (en) 2021-03-23
RS52821B (sr) 2013-10-31
RS52821B2 (sr) 2021-07-30
CN103877091A (zh) 2014-06-25
AR059097A1 (es) 2008-03-12
USRE50189E1 (en) 2024-10-29
JP5836983B2 (ja) 2015-12-24
EA014914B1 (ru) 2011-02-28
KR20140141699A (ko) 2014-12-10
CN101370504A (zh) 2009-02-18
WO2007082922A2 (en) 2007-07-26
BRPI0707179A2 (pt) 2011-04-26

Similar Documents

Publication Publication Date Title
IL192132A0 (en) Long term treatment of hiv-infection with tcm278
HUS1800011I1 (hu) Kombinációs terápia szubsztituált oxazolidinonokkal
GB0610867D0 (en) Treatment of pain
IL193748A0 (en) Treatment of pain
GB0624874D0 (en) Treatment
GB0702931D0 (en) Skin application
GB0909297D0 (en) Composition for the treatment of skin conditions
ZA200901452B (en) Treatment of vertigo with acetyl-L-leucine
GB0600692D0 (en) Well treatment
ZA200806505B (en) Treatment of HIV
GB0723100D0 (en) Treatment of HFnEF
GB0610868D0 (en) Treatment of pain
GB0607952D0 (en) Novel treatment
GB0604460D0 (en) Treatment
GB0714500D0 (en) composition and treatment
GB0616450D0 (en) Treatment of pain
GB0602857D0 (en) The treatment of sialorrhoea
GB0623740D0 (en) Treatment of disease
GB0602855D0 (en) The Treatment Of Sialorrhoea
GB0602858D0 (en) The treatment of sialorrhoea
GB0625602D0 (en) Treatment of sialorrhoea
GB0601091D0 (en) The Treatment Of Ocular Conditions
GB0605781D0 (en) Treatment
GB0610431D0 (en) Treatment
GB0609789D0 (en) Treatment of inflammation